Sitemap
- About Us (RedirectPage)
- Newsroom (newsroom)
- 2013 (contentTopForLists)
- Now Open Broad Agency Announcements (NewsroomArticles)
- FFMN Solicitation No 13-100-SOL-0000 (NewsroomExternalLinks)
- HHSAwardADDevelopmentNovelFlu (NewsroomExternalLinks)
- PAHPA (NewsroomExternalLinks)
- Smart DME-Power Generation RFI (NewsroomExternalLinks)
- RFIAgentsTreatmentNewThreats (NewsroomExternalLinks)
- FDAApprovBotulismAntitoxinHeptavalent (NewsroomExternalLinks)
- Lurie_FDAApprovBotulismAntitoxinHeptavalent (NewsroomExternalLinks)
- Clinical_Studies_Network_RFP (NewsroomExternalLinks)
- TestIdentifyResistantFlu (NewsroomExternalLinks)
- PresolicitationAncillaryInfluPreparedness (NewsroomExternalLinks)
- StrategicAllianceDevAntibiotics (NewsroomExternalLinks)
- BARDA Proposal Public Health and Medical Consequence Modeling Network (NewsroomExternalLinks)
- BARDA Supports New Broad-Spectrum Antibiotic Drug (NewsroomExternalLinks)
- Pre-Solicitation Notice for the Advanced Research and Development (NewsroomExternalLinks)
- Pre-Solicitation Notice for Science and Technology Platforms (NewsroomExternalLinks)
- Pre-Solicitation Notice for the Advancement of Medical Countermeasures (NewsroomExternalLinks)
- HHSBAANewsRelease (NewsroomExternalLinks)
- BAAPreProposalConference (NewsroomExternalLinks)
- SmallMoleculeDev (NewsroomExternalLinks)
- PBS_Report_2012 (NewsroomExternalLinks)
- EvalSevereThermalBurns (NewsroomExternalLinks)
- BARDA evaluates burn dressing for radiation, sulfur mustard burns (NewsroomExternalLinks)
- BARDA funds study of therapy for thermal burns (NewsroomExternalLinks)
- HHS replenishes nation’s supply of anthrax antitoxin (NewsroomExternalLinks)
- HHS pursues nerve agent anti-seizure drug for children and adults (NewsroomArticles)
- HHS boosts stockpile of products to treat acute radiation syndrome (NewsroomExternalLinks)
- HHS boosts national capacity to produce pandemic flu vaccine (NewsroomExternalLinks)
- HHSNewBloodAnthraxTest (NewsroomExternalLinks)
- 2014 (contentTopForLists)
- Drug_Bioterrorism_Antimicrobial-resistant_Infections (NewsroomExternalLinks)
- network to perform clinical studies (NewsroomExternalLinks)
- Now Open Broad Agency Announcements (NewsroomArticles)
- BID2014_RegistrationOpen (NewsroomExternalLinks)
- CIADM_RTOR_Pfenex (NewsroomExternalLinks)
- Establish Adjuvant Hub (NewsroomExternalLinks)
- CIADM_RTOR_Vaxin (NewsroomExternalLinks)
- EbolaFAQ (NewsroomExternalLinks)
- MappEbolaDevelopment (NewsroomExternalLinks)
- ProfectusEbolaVaccine (NewsroomExternalLinks)
- BARDA Chem and RadNuc Animal Model Development (NewsroomExternalLinks)
- develop next-generation portable ventilator (NewsroomExternalLinks)
- severe infections and prevent cytokine storm (NewsroomExternalLinks)
- detection tests for influenza (NewsroomExternalLinks)
- speed Ebola vaccine delivery (NewsroomExternalLinks)
- 2021 (contentTopForLists)
- RegeneronPurchase (NewsroomArticles)
- Lillyincrease (NewsroomArticles)
- VisbyMedical (NewsroomArticles)
- COVID19purchases (NewsroomArticles)
- Luminex (NewsroomArticles)
- LightDeck (NewsroomArticles)
- JanssenEUA (NewsroomArticles)
- Hologic assay4 (NewsroomArticles)
- Lilly (NewsroomArticles)
- MerckJ&J (NewsroomArticles)
- MediciNova (NewsroomArticles)
- ContraFect (NewsroomArticles)
- NCATS (NewsroomArticles)
- DiaSorinSpA (NewsroomArticles)
- FirstString (NewsroomArticles)
- MaskChallenge (NewsroomArticles)
- Janssen (NewsroomArticles)
- ortho (NewsroomArticles)
- ebolataskforce (NewsroomArticles)
- AgileMD (NewsroomArticles)
- PeraHealth (NewsroomArticles)
- BAAAntibacterial (NewsroomArticles)
- BID2021Save (NewsroomArticles)
- 2015 (contentTopForLists)
- 2014 PHEMCE SIP (NewsroomExternalLinks)
- CRO Nonclinical Studies SB (NewsroomExternalLinks)
- CRO Nonclinical Studies Other (NewsroomExternalLinks)
- Universal Flu Vaccine RFP (NewsroomExternalLinks)
- AnthraxVaccine (NewsroomExternalLinks)
- Animal Model Development RFP (NewsroomExternalLinks)
- Continuous Manufacturing RFI (NewsroomExternalLinks)
- AD BS Influenza Monoclonal Antibodies (NewsroomExternalLinks)
- Emergent CIADM Ebola (NewsroomExternalLinks)
- RFP for Advanced Development of Broad-Spectrum Influenza Monoclonal Antibodies (NewsroomExternalLinks)
- DevAnthraxVaccine (NewsroomExternalLinks)
- ExperimentalEbolaVaccine (NewsroomExternalLinks)
- AllianceAntibioticDevelopment (NewsroomExternalLinks)
- DevelopmentMonoclonalAntibodyEbola (NewsroomExternalLinks)
- DisasterUseApprovedClotBusting (NewsroomExternalLinks)
- DevelopmentHospitalizedInfluenzaPatients (NewsroomExternalLinks)
- Novel drug to treat influenza (NewsroomExternalLinks)
- NewProductSevereBurns (NewsroomExternalLinks)
- ImproveInfluenzaVaccines (NewsroomExternalLinks)
- PresolicitationBAAFlu (NewsroomExternalLinks)
- Broad Agency Announcements (NewsroomArticles)
- Coming Soon: Broad Agency Announcements (NewsroomExternalLinks)
- New Skin Substitute (NewsroomExternalLinks)
- Inhalational anthrax treatments (NewsroomExternalLinks)
- Draft RFP Respiratory Illness Live Virus Fill / Finish Services (NewsroomExternalLinks)
- SSN Respiratory Illness Live Virus Fill / Finish Services (NewsroomExternalLinks)
- Manufacturing N95 Respirators (NewsroomExternalLinks)
- 2020 (contentTopForLists)
- Novel Coronavirus (NewsroomExternalLinks)
- nCoV Market Research (NewsroomArticles)
- Coronavirus Emergency (NewsroomExternalLinks)
- AUDENZTM H5N1 (NewsroomExternalLinks)
- Regeneron Therapeutic (NewsroomExternalLinks)
- nCoV EZ BAA (NewsroomExternalLinks)
- Janssen Coronavirus (NewsroomExternalLinks)
- Sanofi nCoV (NewsroomExternalLinks)
- Janssen nCoV (NewsroomExternalLinks)
- COVID19 Diagnostic (NewsroomExternalLinks)
- Hologic Diagnostic (NewsroomArticles)
- COVID-19 Diagnostic Test (NewsroomExternalLinks)
- Cepheid Diagnostic (NewsroomArticles)
- Mesa Biotech COVID-19 (NewsroomArticles)
- Qiagen COVID-19 (NewsroomArticles)
- DiaSorin COVID-19 (NewsroomArticles)
- Janessen COVID-19 various (NewsroomArticles)
- Moderna COVID-19 mRNA (NewsroomArticles)
- Janssen Vaccine COVID-19 (NewsroomArticles)
- Nanomix Diagnostic (NewsroomArticles)
- Cue SARS-CoV-2 (NewsroomArticles)
- Luminex NxTag Diagnostic (NewsroomArticles)
- SAB-185 (NewsroomArticles)
- GenMark Diagnostic (NewsroomArticles)
- Grilfols Plasma (NewsroomArticles)
- Emergent Plasma (NewsroomArticles)
- Luminex Aries Diagnostic (NewsroomArticles)
- Genetech (NewsroomArticles)
- SNS Donations (1) (NewsroomArticles)
- Plasma Immunotherapies (NewsroomArticles)
- DiaSorin (NewsroomArticles)
- OraSure Diagnostic (NewsroomArticles)
- Vela Diagnostic (NewsroomArticles)
- ARC Donors (NewsroomArticles)
- PSC Sanofi Recombinant (NewsroomArticles)
- Hememics Diagnostic (NewsroomArticles)
- Tangen Diagnostic (NewsroomArticles)
- Cytovale Diagnostic (NewsroomArticles)
- Inbios Diagnostic (NewsroomArticles)
- Americas Blood Centers (NewsroomArticles)
- Cerus INTERCEPT (NewsroomArticles)
- Hologic Assay (NewsroomArticles)
- Mayo Clinic (NewsroomArticles)
- Beckman Coulter (NewsroomArticles)
- Phlow US Manufacturing (NewsroomArticles)
- VitalConnect (NewsroomArticles)
- Philips Lumify (NewsroomArticles)
- COVID Vaccine (NewsroomArticles)
- Merck IAVI (NewsroomArticles)
- Genentech Therapeutic (NewsroomArticles)
- Emergent Manufacturing (NewsroomArticles)
- Quidel Diagnostic (NewsroomArticles)
- Siemens Healthineers (NewsroomArticles)
- Evidaton Health wearable (NewsroomArticles)
- Moderna vaccine (NewsroomArticles)
- AstraZeneca (NewsroomArticles)
- ChembioZikaFDA (NewsroomArticles)
- SepsisAlliance (NewsroomArticles)
- Snapdragon (NewsroomArticles)
- OraSurevitro (NewsroomArticles)
- FDA EUA End (NewsroomExternalLinks)
- Regeneron study (NewsroomArticles)
- Immunexpress (NewsroomArticles)
- OrthoClinicalDiagnostics (NewsroomArticles)
- Corning (NewsroomArticles)
- Empatica (NewsroomArticles)
- MBio (NewsroomArticles)
- CSU (NewsroomArticles)
- Sonica (NewsroomArticles)
- BID (NewsroomArticles)
- Chembio DPP (NewsroomArticles)
- SiO2 (NewsroomArticles)
- NovavaxHHSDOD (NewsroomArticles)
- RegeneronHHSDOD (NewsroomArticles)
- LightningTalks2020 (NewsroomArticles)
- RTI (NewsroomArticles)
- BD (NewsroomArticles)
- Smiths (NewsroomArticles)
- Pfizer (NewsroomArticles)
- TAMUS (NewsroomArticles)
- LightningTalksApply (NewsroomArticles)
- Moderna-Phase-3 (NewsroomArticles)
- Sanofi_GSK (NewsroomArticles)
- JanssenRapidARD (NewsroomArticles)
- GrandRiver (NewsroomArticles)
- Diasorin-Antibody-Test (NewsroomArticles)
- ModernaManufacturing (NewsroomArticles)
- BARDA-New-Partnerships (NewsroomArticles)
- NOWDiagnostics (NewsroomArticles)
- Marinus (NewsroomArticles)
- 98point6 (NewsroomArticles)
- OlogyBio (NewsroomArticles)
- Ortho (NewsroomArticles)
- UPenn (NewsroomArticles)
- Luminex (NewsroomArticles)
- LuminexNxTAG (NewsroomArticles)
- Basilea (NewsroomArticles)
- Invirsa (NewsroomArticles)
- antibioticresistant (NewsroomArticles)
- Mapp (NewsroomArticles)
- BARDAMsg (NewsroomArticles)
- Vaxxas (NewsroomArticles)
- CurrentHealth (NewsroomArticles)
- Cepheid (NewsroomArticles)
- AstraZeneca2 (NewsroomArticles)
- Cytiva (NewsroomArticles)
- BeckmanCoulter (NewsroomArticles)
- TRI (NewsroomArticles)
- CSN (NewsroomArticles)
- EZ-BAA (NewsroomArticles)
- Lilly (NewsroomArticles)
- InBios2 (NewsroomArticles)
- Hologic (NewsroomArticles)
- Humanigen (NewsroomArticles)
- MesaBiotech (NewsroomArticles)
- Ventures (NewsroomArticles)
- BID2020Message (NewsroomArticles)
- DiaSorinIgG (NewsroomArticles)
- Siemens (NewsroomArticles)
- SiemensCoV2Ag (NewsroomArticles)
- Chrysalis (NewsroomArticles)
- ENACT (NewsroomArticles)
- Lilly2 (NewsroomArticles)
- Chembio (NewsroomArticles)
- GHTC (NewsroomArticles)
- Moderna (NewsroomArticles)
- QuantumLeap (NewsroomArticles)
- Hologicassay (NewsroomArticles)
- ModernaEUA (NewsroomArticles)
- Ridgeback (NewsroomArticles)
- Merck (1) (NewsroomArticles)
- Pfizer (1) (NewsroomArticles)
- Eoy2020 (NewsroomArticles)
- Challenge (NewsroomArticles)
- DiaSorinSimplexacombo (NewsroomArticles)
- 2016 (contentTopForLists)
- Pre-Solicitation Biological Animal Model Development (NewsroomExternalLinks)
- AntimicrobialResistancePartner (NewsroomExternalLinks)
- Zika Blood Product (NewsroomExternalLinks)
- New BSA Development (NewsroomExternalLinks)
- Zika Diagnostics (NewsroomExternalLinks)
- Decontamination Study (NewsroomExternalLinks)
- Anthrax Diagnostic Test (NewsroomExternalLinks)
- Nasal Anthrax Vaccine (NewsroomExternalLinks)
- Pathogen Reduction Technologies (NewsroomExternalLinks)
- CIADM Zika Vaccine (NewsroomExternalLinks)
- Zika Vaccine Capacity Brazil (NewsroomExternalLinks)
- Regional Ebola Treatment Center (NewsroomExternalLinks)
- CARB-X (NewsroomExternalLinks)
- Zika Diagnostic (NewsroomExternalLinks)
- Single Dose Anthrax (NewsroomExternalLinks)
- Zika Emergency Puerto Rico (NewsroomExternalLinks)
- DiaSorin Zika (NewsroomExternalLinks)
- OraSure Zika (NewsroomExternalLinks)
- Chembio Zika (NewsroomExternalLinks)
- Takeda Zika (NewsroomExternalLinks)
- Moderna Zika (NewsroomExternalLinks)
- AMR Prize (NewsroomExternalLinks)
- New Antibiotics (NewsroomExternalLinks)
- Zika Vaccine Sanofi (NewsroomExternalLinks)
- Bioterrorism Antidote (NewsroomExternalLinks)
- Genetic Sequencing Platform (NewsroomExternalLinks)
- Next Gen Anthrax (NewsroomExternalLinks)
- Tests ebola vaccine (NewsroomExternalLinks)
- Test Radiation Absorbed (NewsroomExternalLinks)
- Radiological Threats (NewsroomExternalLinks)
- New BARDA Director (NewsroomExternalLinks)
- 2017 (contentTopForLists)
- CARB-X Competition (NewsroomExternalLinks)
- CARB-X Drug Discovery and Dev (NewsroomExternalLinks)
- Zika Diagnostic (NewsroomExternalLinks)
- High-Throughput Biodosimetry (NewsroomExternalLinks)
- Point of Care Biodosimetry Tests (NewsroomExternalLinks)
- RFP Biodosimetry POC (NewsroomExternalLinks)
- RFP Biodosimetry High Throughput (NewsroomExternalLinks)
- CARB-X Announces Funding for Global Scientists (NewsroomExternalLinks)
- New Antibiotic (NewsroomExternalLinks)
- Antibiotic Ridinilazole (NewsroomExternalLinks)
- Janssen Influenza (NewsroomExternalLinks)
- Cyanide Intranasal (NewsroomExternalLinks)
- Anthrax POC Test (NewsroomExternalLinks)
- Respiratory Drug Chemical Antidote (NewsroomExternalLinks)
- Smallpox Vaccine Special Pop (NewsroomExternalLinks)
- Ebola Vaccines (NewsroomExternalLinks)
- Reusable Respirator (NewsroomExternalLinks)
- Influenza and EID (NewsroomExternalLinks)
- Radiation Exposure Tests (NewsroomExternalLinks)
- Infection Antibiotic (NewsroomExternalLinks)
- Radiation Blood Platelets (NewsroomExternalLinks)
- CARB-X Amicidin-β (NewsroomExternalLinks)
- 2018 BAA (NewsroomExternalLinks)
- Anthrax Diagnostic (NewsroomExternalLinks)
- 2018 (contentTopForLists)
- Leukine ARS (NewsroomExternalLinks)
- ENACT and Sepsis (NewsroomArticles)
- Decontamination (NewsroomExternalLinks)
- DRIVe Funding (NewsroomExternalLinks)
- Antrhrax SNS Purchase (NewsroomExternalLinks)
- Nerve Agent (NewsroomExternalLinks)
- Philadelphia Accelerator (NewsroomExternalLinks)
- Houston Accelerator (NewsroomExternalLinks)
- New York Accelerator (NewsroomExternalLinks)
- New Orleans Accelerator (NewsroomExternalLinks)
- Los Angeles Accelerator (NewsroomExternalLinks)
- Greater Boston Accelerator (NewsroomExternalLinks)
- Raleigh-Durham Accelerator (NewsroomExternalLinks)
- Seattle-Bellevue Accelerator (NewsroomExternalLinks)
- BID2018 (NewsroomArticles)
- TPOXX (NewsroomExternalLinks)
- Novel (NewsroomExternalLinks)
- Lightning Talk Applications (NewsroomArticles)
- flu test (NewsroomExternalLinks)
- Sulfur Mustard (NewsroomExternalLinks)
- Faster Tests (NewsroomExternalLinks)
- Smallpox Antiviral (NewsroomExternalLinks)
- Genentech (NewsroomExternalLinks)
- Burn Dressing (NewsroomExternalLinks)
- Security Threats (NewsroomExternalLinks)
- 2019 (contentTopForLists)
- Expand Accelerators (NewsroomExternalLinks)
- Marburg (NewsroomExternalLinks)
- BurnDeepView (NewsroomExternalLinks)
- VenatoRx (NewsroomExternalLinks)
- SilverlonSulferMustard (NewsroomExternalLinks)
- Lightning Talk Applications 2019 (NewsroomArticles)
- Smallpox Vaccine Purchase SNS (NewsroomExternalLinks)
- Expand Accelerator Network (NewsroomExternalLinks)
- Investigational Ebola Treatment (NewsroomExternalLinks)
- Smallpox and Monkeypox Licensed Vaccine (NewsroomExternalLinks)
- Blood Platelets (NewsroomExternalLinks)
- Filovirus Vaccines (NewsroomExternalLinks)
- Lung Chip (NewsroomExternalLinks)
- Lightning Talks Selectees (NewsroomArticles)
- ebola RDT (NewsroomExternalLinks)
- Sepsis Algorithm (NewsroomExternalLinks)
- Cytovale Sepsis (NewsroomExternalLinks)
- Bacterial from Viral (NewsroomExternalLinks)
- Modernize Influenza (NewsroomExternalLinks)
- Anthrax Lung Infections (NewsroomExternalLinks)
- Ebola Vaccine (NewsroomExternalLinks)
- Archive (Content)
- Enalare (NewsroomArticles)
- Enalare (RedirectPage)
- 2013 (contentTopForLists)
- Federal Initiatives (FederalInitiatives)
- Public Meetings (contentFed)
- BARDA Industry Day 2019 (conference)
- Hotel Accommodations (Content)
- Directions (Content)
- About BARDA Industry Day (Content)
- FAQ (Content)
- Hybrid Events (Content)
- Speakers (Content)
- presentations (Content)
- BARDA Industry Day 2017 (conference)
- Presentations (Content)
- About BARDA BID (Content)
- Hotel Accommodations (Content)
- Keynote Speaker (Content)
- BARDA Industry Day 2016 (conference)
- Why Attend (Content)
- Meeting Opportunities (Content)
- Hotel Accommodations (Content)
- Breakout Session Opportunities (Content)
- Presentations (Content)
- BARDA Industry Day 2018 (conference)
- Hotel Accommodations (Content)
- Directions (Content)
- About BARDA Industry Day (Content)
- Presentations (Content)
- Keynote Speaker (Content)
- Lightning Talks (Content)
- HHS Summit to Accelerate Zika Diagnostics Development (conference)
- JPM-MCS Industry Day : Proposed Other Transaction Agreement (conference)
- BARDA Industry Day 2015 (conference)
- Why Attend (Content)
- Meeting Opportunities (Content)
- Hotel Accommodations (Content)
- Presentations (Content)
- WorkshopBID2014 (conference)
- Workshop2014WhyAttend (Content)
- Workshop2014MeetingOpportunity (Content)
- hotels (Content)
- Presentations - BARDA Industry Day 2014 (Content)
- WorkshopBID2013 (conference)
- Workshop2013WhyAttend (Content)
- Workshop2013MeetingOpportunity (Content)
- hotels (Content)
- Presentations - BARDA Industry Day 2013 (Content)
- BAAPreProposalConference2013 (conference)
- WorkshopBID2012 (conference)
- Workshop2012MeetingOpportunity (Content)
- Workshop2012WhoAttends (Content)
- Workshop2012Register (Content)
- Workshop2012WhyAttend (Content)
- Presentations (Content)
- Announcement1026 (Content)
- Announcement1028 (Content)
- PreProposalConference2012 (conference)
- guidlines (Content)
- BloodSymposium (conference)
- WorkshopBoston (conference)
- Presentations (Content)
- WorkshopBostonWhoAttends (Content)
- WorkshopBostonMeetingOpportunity (Content)
- WorkshopBostonRegister (Content)
- PHEMCE Stakeholders Workshop 2016 (conferenceLink)
- 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day (conferenceLink)
- HHS PHEMCE Stakeholders Workshop 2009 and BARDA Industry Day (conferenceLink)
- CBRN Medical Countermeasures Workshop (conferenceLink)
- HHS PHEMCE Stakeholders Workshop 2008 and BARDA Industry Day (conferenceLink)
- 2007 Biomedical Advanced Research and Development Authority (BARDA) Industry Day (conferenceLink)
- HHS PHEMC Enterprise Stakeholders Workshop (conferenceLink)
- BioShield Stakeholders Workshop (conferenceLink)
- BARDA Industry Day 2020 (conferenceLink)
- BARDA Vaccines Against AMR Threats Workshop (conferenceLink)
- BID2021 (conferenceLink)
- BARDA Industry Day 2019 (conference)
- Procurements and Grants (contentFed)
- Federal Government Procurement Activities (contentFedItem)
- Grants (contentFedItem)
- Department and Agency Resources (contentFedItem)
- Acquisition Regulations (contentFedItem)
- Other Procurements and Grants Resources (contentFedItem)
- Strategies and Reports (contentFed)
- Strategies and Reports (contentFedItem)
- Public Health Emergency Medical Countermeasures Enterprise (contentFedItem)
- NIH Strategic Planning (contentFedItem)
- Pandemic Influenza (contentFedItem)
- CBRN and Medical Countermeasure Reports (contentFedItem)
- External Resources (contentFedItem)
- Guidance (contentFed)
- Emergency Preparedness and Response (contentFedItem)
- Drugs (contentFedItem)
- Vaccines Blood and Biologics (contentFedItem)
- Devices (contentFedItem)
- Select Agent Rule (contentFedItem)
- Animal Rule (contentFedItem)
- Good Laboratory Practices (contentFedItem)
- Technology Readiness Levels (contentFedItem)
- Guidance Regarding Specific Types of Medical Countermeasures (contentFedItem)
- Acquisition Regulations (contentFedItem)
- Resources (contentFed)
- Microbiology (contentFedItem)
- Immunology and Testing (contentFedItem)
- Genomics (contentFedItem)
- Public Meetings (contentFed)
- Request BARDA TechWatch Meeting (uSGCoronaWatch)
- NewsroomRSS (Content)
- PHEMCE (pHEMCE)
- PHEMCE Strategy and Implementation (Content)
- Requirements Setting (GenericWithSideBar)
- HHS PHEMCE Strategy (Content)
- NIH (pHEMCESubPage)
- CDC (GenericSingleColWithSideBar)
- DHS (GenericSingleColWithSideBar)
- FDA (GenericSingleColWithSideBar)
- DOD (GenericSingleColWithSideBar)
- ASPR (GenericSingleColWithSideBar)
- ProjectMaps (ContentTop)
- Domestic (Content)
- International (Content)
- Who (Content)
- Summary (Content)
- Conference Survey (Content)
- prism (RedirectPage)
- 2017 Conference Survey (Content)
- Sitemap (Content)
- Lightning Talks (Content)
- XmlSitemap (xmlSiteMap)
- Home5 (Content)
- BARDA (bardaNew)
- CBRN (cBRNNew)
- Project BioShield Overview (GenericSingleColWithSideBar)
- Project BioShield Annual Report (Content)
- Project BioShield Funding (Content)
- 2009CBRNWorkshop (Content)
- 2009CBRNVideo1 (Content)
- 2009CBRNVideo2 (Content)
- CBRN Funding Activities (RedirectPage)
- PRISM (GenericSingleColWithSideBar)
- decontamination guidance for chemical incidents (RedirectPage)
- Botulinum Toxin (Content)
- Chemical Medical Countermeasures (Content)
- Radiological and Nuclear Countermeasures (Content)
- Radiation Exposure (Content)
- Broad Spectrum Antimicrobials (Content)
- Diagnostics and Biodosimetry (Content)
- Biothreat Diagnostics Program (Subcontentwithtab)
- Biodosimetry Program (Subcontentwithtab)
- Thermal Burn (Content)
- Ebola (Content)
- Ebola Therapeutics Program (Subcontentwithtab)
- Ebola Vaccines Program (Subcontentwithtab)
- Smallpox (Content)
- Smallpox Antivirals Program (Subcontentwithtab)
- Smallpox Vaccines Program (Subcontentwithtab)
- MDRVaccines (aMR)
- Project BioShield Overview (GenericSingleColWithSideBar)
- Core Services (GenericSingleColWithSideBar)
- Strategic Investor (Content)
- Medical Countermeasures for Anthrax (Content)
- Medical Countermeasures for Smallpox (Content)
- Radiological and Nuclear Threats (Content)
- CBRN Diagnostics and Biodosimetry (Content)
- Regulatory and Quality Affairs (Content)
- Animal Studies Program (Content)
- Clinical Studies Support (Content)
- Modeling Hub (Content)
- CIADM (Content)
- CIADMGovernance (Content)
- Fill Finish Manufacturing Network (Content)
- Stockpile Building (GenericSingleColWithSideBar)
- Project BioShield Annual Report (Content)
- Project BioShield Funding (Content)
- Popular Resources (GenericSingleColWithSideBar)
- Influenza And Emerging Infectious Diseases (GenericSingleColWithSideBar)
- Pandemic Influenza Preparedness Spending Reports (Content)
- Influenza Vaccine Development Programs (Content)
- Pandemic Influenza Vaccine Stockpile Program (Content)
- Influenza Diagnostics Program (Content)
- Influenza Therapeutics Program (Content)
- Influenza Vaccine Manufacturing Infrastructure (Content)
- International Influenza Vaccine Manufacturing Capacity Building Program (Content)
- Coronavirus (GenericSingleColWithSideBar)
- Pharmaceutical Manufacturing in America (manufacturing)
- PHEMCE Management (GenericWithSideBar)
- HHS PHEMCE Strategy And Implementation (Content)
- 2008 PHEMCE Stakeholders Workshop (Content)
- 2010 PHEMCE Stateholders Workshop (Content)
- 2010SWBeakoutSessions (Content)
- 2010SWPresentations (Content)
- 2010SWWhoAttends (Content)
- 2010SWHotList (Content)
- 2010SWContactUs (Content)
- 2009 PHEMCE Stakeholders Workshop (Content)
- 2009SWBreakoutSessions (Content)
- 2009SWPresentations (Content)
- 2009SWWhoAttends (Content)
- 2009SWContactUs (Content)
- 2007 BARDA Day (Content)
- 2007 PHEMCE Stakeholders Workshop (Content)
- 2006 BioShield Stakeholders Workshop (Content)
- 2006 BioShield Agenda (Content)
- Requirements Setting (GenericWithSideBar)
- HHS PHEMCE Strategy (Content)
- Emerging Infectious Diseases (GenericSingleColWithSideBar)
- test page (Content)
- WhoWeAre (whoWeAreNew)
- BARDA COVID-19 Response (covid19New)
- BARDA Industry Day 2020 (bid)
- LT Selectees (bIDStdSubpageNew)
- Bid Presentations (bIDStdSubpageNew1)
- FAQ 2020 (fAQNew)
- BARDA BAA (bAANew)
- Be A Responder (joinTheFightNew)
- Series (seriesNew)
- QIAGEN LLC (seriesItem2020)
- Cytovale Inc. (seriesItem2020)
- Nanomix Inc. (seriesItem2020)
- Cue Inc. (seriesItem2020)
- GenMark Diagnostics, Inc. (seriesItem2020)
- Emergent BioSolutions (seriesItem2020)
- Ortho Clinical Diagnostics (seriesItem2020)
- Empatica Inc. (seriesItem2020)
- Mesa Biotech Inc. (seriesItem2020)
- Grifols (seriesItem2020)
- Cerus (seriesItem2020)
- Immunexpress Inc. (seriesItem2020)
- Janssen Research & Development, LLC (seriesItem2020)
- Luminex Corporation (seriesItem2020)
- Retractable Technologies, Inc. (seriesItem2020)
- OraSure Technologies, Inc. (seriesItem2020)
- SiO2 Materials Science (seriesItem2020)
- MBio Diagnostics (seriesItem2020)
- Tangen Biosciences, Inc. (seriesItem2020)
- Colorado State University (seriesItem2020)
- InBios (seriesItem2020)
- Smiths Medical (seriesItem2020)
- Corning Incorporated (seriesItem2020)
- Grand River Aseptic Manufacturing, Inc. (seriesItem2020)
- SAb Biotherapeutics (seriesItem2020)
- Chembio (seriesItem2020)
- Making Countermeasures (seriesVideoItem2020)
- ImpactBurnCare (seriesItem2020)
- Numerous (seriesItem2020)
- FDAapprovals (fDANew)
- Advancing Innovation (innovationNew)
- BARDA Sepsis Awareness Month (sepsis)
- TechWatch (RedirectPage)
- Research (bardaResearchNew)
- Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) (bardaResearchItemNew)
- Development of a clinical assay to measure chlorinated tyrosine (bardaResearchItemNew)
- Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012–2018 (bardaResearchItemNew)
- Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012–2018 (bardaResearchItemNew)
- Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012–2018 (bardaResearchItemNew)
- Evaluation of BioThrax® and AV7909 Anthrax Vaccines in Adults 66 Years of Age or Older (bardaResearchItemNew)
- Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus (bardaResearchItemNew)
- Current State of Anthrax Vaccines and Key R&D Gaps Moving Forward (bardaResearchItemNew)
- CBRN (cBRNNew)
- Video Library (videoLibrary)
- CBRNDirectorBID2020 (videoLibraryVideo)
- BARDACOVIDResponse (videoLibraryVideo)
- COVID19_MCM Investments (videoLibraryVideo)
- MakingCountermeasuresSeries (videoLibraryVideo)
- DirectorEUA (videoLibraryVideo)
- DRIVEProgram (videoLibraryVideo)
- AMR Workshop (videoLibraryVideo)
- CARBXPartnership (videoLibraryVideo)
- BioTalkCatalyst (videoLibraryVideo)
- COVIDVaccineHesitancy (videoLibraryVideo)
- ASKBARDA_CTPaused (videoLibraryVideo)
- ASKBARDA_CTSafety (videoLibraryVideo)
- ASKBARDA_CTPlanned (videoLibraryVideo)
- ASKBARDA_CTPlacebo (videoLibraryVideo)
- ASKBARDA_CTDSMB (videoLibraryVideo)
- ASKBARDA_CTOutcome (videoLibraryVideo)
- PublicPrivatePartnerships (videoLibraryVideo)
- PBS_BuildMCM (videoLibraryVideo)
- CARBXDRIVE (videoLibraryVideo)
- DRIVeInnovation (videoLibraryVideo)
- BeyondLab (videoLibraryVideo)
- BID2020 (videoLibraryVideo)
- Blogs (blogs)
- BARDAVentures (blog)
- InnovationChallenge (blog)
- Antibiotic Partnerships (blog)
- Ebola Efforts Continue (blog)
- Strong partnerships next generation antibiotics (blog)
- Flu Drug Earns FDA Approval (blog)
- Reflections on antibiotic resistance (blog)
- Crash Course (blog)
- Zika receives FDA Clearance (blog)
- Evolving Federal National Health Security (blog)
- 50 Million Diagnostic Tests Shipped (blog)
- Clinical Synergies (blog)
- Sepsis Solutions Help Covid Patients (blog)
- Critical Time For Public Service (blog)
- Raising Awareness (blog)
- BARDA Leverages Strong Partnerships (blog)
- Sepsis Skyrocketing (blog)
- Vaccine Uses Next Gen Technology (blog)
- Need for Speed (blog)
- Threat In My Backyard (blog)
- Power of Partnerships (blog)
- Close Encounter (blog)
- Crossing The Finish Line (blog)
- Novel Partnerships (blog)
- Building Better Pipeline of Products (blog)
- Leveraging Project BioShield (blog)
- Strengthening Antibiotics Pipeline (blog)
- Ebola Therapeutic (blog)
- Business Models to Enhance Antibiotic Development (blog)
- BSA Program (blog)
- Responding to the Threat (blog)
- Antibiotic Resistance and Why a Problem (blog)
- Changing Pandemic Influenza Vaccine Manufacturing (blog)
- Build and Sustain Robust MCM Pipeline (blog)
- Award Winning Pan Flu Preparedness (blog)
- Plan to Keep the Nation Safe (blog)
- Can Rapid, Near-Patient Flu Tests Improve Preparedness and Response (blog)
- BioShield (blog)
- Pandemic Influenza (blog)
- FDA Anti Seizure (blog)
- BARDA Partners (blog)
- New Smallpox (blog)
- 1918 to 2018 (blog)
- Decontamination Decoded (blog)
- BARDA Supports a Rapid Deployable (blog)
- BARDA Adds New Antibiotic (blog)
- New Frontiers and Extreme Environments (blog)
- Powering The Next Gen (blog)
- Next Generation Burn Care (blog)
- Better Preparing (blog)
- Anticipating Threats (blog)
- PHEMCE-Supported Drug Achieves FDA Approval (blog)
- Would Old Vaccine Work (blog)
- BARDA Seeks to Launch a Novel Partnership (blog)
- Better Protecting (blog)
- Bird Flu (blog)
- Fighting Antibiotic Resistance (blog)
- BARDA-Supported Zika Vaccine Candidate (blog)